NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ViewsML

ViewsML

Private
VancouverHealthcare & Life Scienceshttps://www.viewsml.com/

Last Round

Seed

Apr 20, 2026

Total Funding Raised

$3.54M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

ViewsML is a healthcare IT company that has developed an AI-powered platform and virtual biomarker library to generate per-cell biomarker spatial insights from standard pathology images, eliminating the need for physical laboratory staining.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Precision Medicine, Drug Discovery, Medical Imaging, Clinical Trials

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

virtual stainingvirtual immunohistochemistryvIHCcomputational pathologybiomarker analysisdigital pathologyAI diagnosticstechbiovirtual biomarkersimmunohistochemistryIHCH&E stainingdrug developmentprecision medicinequantitative pathologyclinical trial stratification

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ViewsML Comps

Public and private peers based on sector, stage, and business model.

ViewsML comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ViewsML Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 20, 2026
SeedApr 1, 2024

Key People

Founding team and executive leadership

Kenneth To

Chief Executive Officer

Executive Team

ViewsML Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    $3.5M raised in Seed round.

  • Feb 2, 2026

    Monthly visitors grew 240% MoM, from 454 to 1.5K.

ViewsML Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ViewsML Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ViewsML's valuation, stock price, and market status.

Firmographic Details

HeadquartersVancouver
Employee Range14
Year Founded2022
Last FundingApr 20, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.